Publications by Erik Øie
96 publications found
Original articles
Long-Term Outcomes of Invasive vs Conservative Strategies for Older Patients With Non-ST-Segment Elevation Acute Coronary Syndromes
J Am Coll Cardiol, 82 (21), 2021-2030
DOI 10.1016/j.jacc.2023.09.809, PubMed 37968019
Left atrial dyssynchrony in veteran endurance athletes with and without paroxysmal atrial fibrillation
Echocardiography, 40 (7), 679-686
DOI 10.1111/echo.15634, PubMed 37279187
Impact of neighbourhood-level socioeconomic status, traditional coronary risk factors, and ancestry on age at myocardial infarction onset: A population-based register study
BMC Cardiovasc Disord, 22 (1), 447
DOI 10.1186/s12872-022-02880-7, PubMed 36289452
Impact of systematic medication review in emergency department on patients' post-discharge outcomes-A randomized controlled clinical trial
PLoS One, 17 (9), e0274907
DOI 10.1371/journal.pone.0274907, PubMed 36121830
Right Heart Structure and Function in Lifelong Recreational Endurance Athletes with and without Paroxysmal Atrial Fibrillation
J Am Soc Echocardiogr, 35 (12), 1259-1268
DOI 10.1016/j.echo.2022.06.008, PubMed 35760278
Drug-related emergency department visits: prevalence and risk factors
Intern Emerg Med, 17 (5), 1453-1462
DOI 10.1007/s11739-022-02935-9, PubMed 35129789
Emergency department physicians' distribution of time in the fast paced-workflow-a novel time-motion study of drug-related activities
Int J Clin Pharm, 44 (2), 448-458
DOI 10.1007/s11096-021-01364-6, PubMed 34939132
Left atrial function in male veteran endurance athletes with paroxysmal atrial fibrillation
Eur Heart J Cardiovasc Imaging, 23 (1), 137-146
DOI 10.1093/ehjci/jeab248, PubMed 34849678
Hypokalemia Promotes Arrhythmia by Distinct Mechanisms in Atrial and Ventricular Myocytes
Circ Res, 126 (7), 889-906
DOI 10.1161/CIRCRESAHA.119.315641, PubMed 32070187
Impact of genotype-predicted CYP2D6 metabolism on clinical effects and tolerability of metoprolol in patients after myocardial infarction - a prospective observational study
Eur J Clin Pharmacol, 76 (5), 673-683
DOI 10.1007/s00228-020-02832-0, PubMed 31940084
Potassium infusion increases the likelihood of conversion of recent-onset atrial fibrillation-A single-blinded, randomized clinical trial
Am Heart J, 221, 114-124
DOI 10.1016/j.ahj.2019.12.014, PubMed 31986288
Screening for symptoms of depression and anxiety in a cardiology department
Tidsskr Nor Laegeforen, 139 (14)
DOI 10.4045/tidsskr.18.0570, PubMed 31592606
Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction
EBioMedicine, 46, 264-273
DOI 10.1016/j.ebiom.2019.07.024, PubMed 31345784
Electrolyte imbalances in an unselected population in an emergency department: A retrospective cohort study
PLoS One, 14 (4), e0215673
DOI 10.1371/journal.pone.0215673, PubMed 31022222
Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments
Eur J Clin Pharmacol, 74 (3), 323-330
DOI 10.1007/s00228-017-2374-4, PubMed 29149366
Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction
BMC Cardiovasc Disord, 16, 115
DOI 10.1186/s12872-016-0283-6, PubMed 27246583
Altered Levels of Fatty Acids and Inflammatory and Metabolic Mediators in Epicardial Adipose Tissue in Patients With Systolic Heart Failure
J Card Fail, 21 (11), 916-23
DOI 10.1016/j.cardfail.2015.07.014, PubMed 26231517
[A woman in her 50s with heavy breathing and hypotension]
Tidsskr Nor Laegeforen, 134 (18), 1758-61
DOI 10.4045/tidsskr.13.1110, PubMed 25273250
Tetradecylthioacetic acid increases fat metabolism and improves cardiac function in experimental heart failure
Lipids, 48 (2), 139-54
DOI 10.1007/s11745-012-3749-z, PubMed 23266898
Disturbed carnitine regulation in chronic heart failure--increased plasma levels of palmitoyl-carnitine are associated with poor prognosis
Int J Cardiol, 167 (5), 1892-9
DOI 10.1016/j.ijcard.2012.04.150, PubMed 22622056
Secretogranin II; a protein increased in the myocardium and circulation in heart failure with cardioprotective properties
PLoS One, 7 (5), e37401
DOI 10.1371/journal.pone.0037401, PubMed 22655045
The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure
PLoS One, 7 (3), e33038
DOI 10.1371/journal.pone.0033038, PubMed 22427939
A complex interaction between Rickettsia conorii and Dickkopf-1--potential role in immune evasion mechanisms in endothelial cells
PLoS One, 7 (9), e43638
DOI 10.1371/journal.pone.0043638, PubMed 23028464
Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failure
PLoS One, 7 (5), e36815
DOI 10.1371/journal.pone.0036815, PubMed 22615818
Intramyocardial injections of human mesenchymal stem cells following acute myocardial infarction modulate scar formation and improve left ventricular function
Cell Transplant, 21 (8), 1697-709
DOI 10.3727/096368911X627462, PubMed 22410280
Krill oil attenuates left ventricular dilatation after myocardial infarction in rats
Lipids Health Dis, 10, 245
DOI 10.1186/1476-511X-10-245, PubMed 22206454
Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality
J Intern Med, 270 (3), 263-72
DOI 10.1111/j.1365-2796.2011.02384.x, PubMed 21466599
Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size
Heart, 97 (6), 460-5
DOI 10.1136/hrt.2010.206714, PubMed 21270073
Mechanisms of novel cardioprotective functions of CCN2/CTGF in myocardial ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, 300 (4), H1291-302
DOI 10.1152/ajpheart.00604.2010, PubMed 21186275
Activation of Notch signaling in cardiomyocytes during post-infarction remodeling
Scand Cardiovasc J, 44 (6), 359-66
DOI 10.3109/14017431.2010.511256, PubMed 20799913
Chromogranin B in heart failure: a putative cardiac biomarker expressed in the failing myocardium
Circ Heart Fail, 3 (4), 503-11
DOI 10.1161/CIRCHEARTFAILURE.109.867747, PubMed 20519641
Increased YKL-40 expression in patients with carotid atherosclerosis
Atherosclerosis, 211 (2), 589-95
DOI 10.1016/j.atherosclerosis.2010.02.035, PubMed 20347092
Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation
Cardiovasc Res, 86 (2), 265-73
DOI 10.1093/cvr/cvq044, PubMed 20139115
Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors
BMC Cancer, 10, 6
DOI 10.1186/1471-2407-10-6, PubMed 20053285
Adrenomedullin is increased in alveolar macrophages and released from the lungs into the circulation in severe heart failure
Basic Res Cardiol, 105 (1), 89-98
DOI 10.1007/s00395-009-0070-y, PubMed 19823891
Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis
Neuroendocrinology, 92 (3), 168-77
DOI 10.1159/000318014, PubMed 20720391
The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis
Thromb Haemost, 102 (4), 704-10
DOI 10.1160/TH08-10-0665, PubMed 19806256
Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling
Circ Heart Fail, 2 (6), 624-32
DOI 10.1161/CIRCHEARTFAILURE.108.821074, PubMed 19919988
Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis
Arterioscler Thromb Vasc Biol, 29 (8), 1228-34
DOI 10.1161/ATVBAHA.109.189761, PubMed 19498175
Up-regulation of myocardial DNA base excision repair activities in experimental heart failure
Mutat Res, 666 (1-2), 32-8
DOI 10.1016/j.mrfmmm.2009.03.008, PubMed 19481677
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
Eur Heart J, 30 (10), 1229-36
DOI 10.1093/eurheartj/ehp088, PubMed 19329498
Elevated levels of activin A in clinical and experimental pulmonary hypertension
J Appl Physiol (1985), 106 (4), 1356-64
DOI 10.1152/japplphysiol.90719.2008, PubMed 19196915
Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis
Circ Res, 104 (1), 60-8
DOI 10.1161/CIRCRESAHA.108.188078, PubMed 19023130
Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability
Stroke, 39 (11), 3092-5
DOI 10.1161/STROKEAHA.108.517128, PubMed 18723424
The complex role of T-cell-based immunity in atherosclerosis
Curr Atheroscler Rep, 10 (3), 236-43
DOI 10.1007/s11883-008-0037-8, PubMed 18489852
Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure
J Mol Cell Cardiol, 45 (2), 261-9
DOI 10.1016/j.yjmcc.2008.05.009, PubMed 18585734
Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure
Eur J Heart Fail, 10 (4), 352-9
DOI 10.1016/j.ejheart.2008.02.010, PubMed 18353719
High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins
Cardiovasc Res, 79 (1), 195-203
DOI 10.1093/cvr/cvn071, PubMed 18339644
Endothelial S100A1 modulates vascular function via nitric oxide
Circ Res, 102 (7), 786-94
DOI 10.1161/CIRCRESAHA.108.172031, PubMed 18292599
A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins
Arterioscler Thromb Vasc Biol, 28 (5), 1005-11
DOI 10.1161/ATVBAHA.108.162305, PubMed 18276907
Atherosclerotic plaque stability--what determines the fate of a plaque?
Prog Cardiovasc Dis, 51 (3), 183-94
DOI 10.1016/j.pcad.2008.09.001, PubMed 19026853
Cardiac-restricted expression of the carboxyl-terminal fragment of GRK3 Uncovers Distinct Functions of GRK3 in regulation of cardiac contractility and growth: GRK3 controls cardiac alpha1-adrenergic receptor responsiveness
J Biol Chem, 283 (16), 10601-10
DOI 10.1074/jbc.M708912200, PubMed 18165681
The role of statins in heart failure
Fundam Clin Pharmacol, 21 Suppl 2, 35-40
DOI 10.1111/j.1472-8206.2007.00538.x, PubMed 18001320
Raised LIGHT levels in pulmonary arterial hypertension: potential role in thrombus formation
Am J Respir Crit Care Med, 177 (2), 202-7
DOI 10.1164/rccm.200703-506OC, PubMed 17962639
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization
Circulation, 115 (8), 972-80
DOI 10.1161/CIRCULATIONAHA.106.665893, PubMed 17283255
Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization
Arterioscler Thromb Vasc Biol, 27 (3), 614-20
DOI 10.1161/01.ATV.0000255581.38523.7c, PubMed 17170367
Induction of pulmonary connective tissue growth factor in heart failure is associated with pulmonary parenchymal and vascular remodeling
Cardiovasc Res, 74 (2), 323-33
DOI 10.1016/j.cardiores.2006.12.010, PubMed 17254558
Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation
J Am Coll Cardiol, 48 (8), 1591-9
DOI 10.1016/j.jacc.2006.06.060, PubMed 17045893
Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes
Blood, 108 (3), 928-35
DOI 10.1182/blood-2005-09-010629, PubMed 16861346
Increased expression and function of the myocardial Na-K-2Cl cotransporter in failing rat hearts
Basic Res Cardiol, 101 (6), 471-8
DOI 10.1007/s00395-006-0604-5, PubMed 16783486
Thalidomide attenuates the development of fibrosis during post-infarction myocardial remodelling in rats
Eur J Heart Fail, 8 (8), 790-6
DOI 10.1016/j.ejheart.2006.02.007, PubMed 16549389
Systemic inflammation in heart failure--the whys and wherefores
Heart Fail Rev, 11 (1), 83-92
DOI 10.1007/s10741-006-9196-2, PubMed 16819581
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization
Arterioscler Thromb Vasc Biol, 26 (4), 857-63
DOI 10.1161/01.ATV.0000204334.48195.6a, PubMed 16424351
Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure
Circulation, 111 (19), 2461-8
DOI 10.1161/01.CIR.0000165119.62099.14, PubMed 15883214
Induction of myocardial connective tissue growth factor in pacing-induced heart failure in pigs
Acta Physiol Scand, 184 (1), 27-36
DOI 10.1111/j.1365-201X.2005.01416.x, PubMed 15847641
RAMP2 and RAMP3 mRNA levels are increased in failing rat cardiomyocytes and associated with increased responsiveness to adrenomedullin
J Mol Cell Cardiol, 38 (1), 145-51
DOI 10.1016/j.yjmcc.2004.10.009, PubMed 15623431
Mechanisms of elevated plasma endothelin-1 in CHF: congestion increases pulmonary synthesis and secretion of endothelin-1
Cardiovasc Res, 63 (1), 41-50
DOI 10.1016/j.cardiores.2004.03.016, PubMed 15194460
Elevated levels of activin A in heart failure: potential role in myocardial remodeling
Circulation, 109 (11), 1379-85
DOI 10.1161/01.CIR.0000120704.97934.41, PubMed 14993131
Connective tissue growth factor--a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats
J Mol Cell Cardiol, 36 (3), 393-404
DOI 10.1016/j.yjmcc.2003.12.004, PubMed 15010278
Induction of myocardial biglycan in heart failure in rats--an extracellular matrix component targeted by AT(1) receptor antagonism
Cardiovasc Res, 60 (3), 557-68
DOI 10.1016/j.cardiores.2003.08.017, PubMed 14659801
Early intervention with a potent endothelin-A/endothelin-B receptor antagonist aggravates left ventricular remodeling after myocardial infarction in rats
Basic Res Cardiol, 97 (3), 239-47
DOI 10.1007/s003950200017, PubMed 12061394
Endothelin receptor antagonism attenuates cardiomyocyte apoptosis after induction of ischemia in rats
Scand Cardiovasc J, 36 (2), 108-16
DOI 10.1080/140174302753675401, PubMed 12028875
Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats
Am J Physiol Heart Circ Physiol, 281 (6), H2490-9
DOI 10.1152/ajpheart.2001.281.6.H2490, PubMed 11709416
Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure
Eur J Clin Invest, 31 (5), 389-97
DOI 10.1046/j.1365-2362.2001.00795.x, PubMed 11380590
Gene expression of natriuretic peptides and their receptors type-A and -C after myocardial infarction in rats
Scand J Clin Lab Invest, 61 (2), 139-50
DOI 10.1080/00365510151097665, PubMed 11347981
Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure
Cardiovasc Res, 47 (4), 778-87
DOI 10.1016/s0008-6363(00)00142-5, PubMed 10974226
Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats
Am J Physiol Heart Circ Physiol, 278 (6), H2115-23
DOI 10.1152/ajpheart.2000.278.6.H2115, PubMed 10843911
Regulation of ET: pulmonary release of ET contributes to increased plasma ET levels and vasoconstriction in CHF
Am J Physiol Heart Circ Physiol, 278 (4), H1299-310
DOI 10.1152/ajpheart.2000.278.4.H1299, PubMed 10749728
Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats
Circulation, 101 (4), 415-22
DOI 10.1161/01.cir.101.4.415, PubMed 10653834
ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats
Am J Physiol, 275 (3), H868-77
DOI 10.1152/ajpheart.1998.275.3.H868, PubMed 9724291
Endothelin-1 is upregulated during skeletal muscle ischemia and reperfusion
J Orthop Res, 16 (1), 128-35
DOI 10.1002/jor.1100160122, PubMed 9565085
Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats
Am J Physiol, 273 (4), H1727-36
DOI 10.1152/ajpheart.1997.273.4.H1727, PubMed 9362237
Increased cardiac expression of endothelin-1 mRNA in ischemic heart failure in rats
Cardiovasc Res, 33 (3), 601-10
DOI 10.1016/s0008-6363(96)00266-0, PubMed 9093530
Review articles
Chemokines and cardiovascular risk
Arterioscler Thromb Vasc Biol, 28 (11), 1909-19
DOI 10.1161/ATVBAHA.107.161240, PubMed 18669888
Role of inflammation in the progression of heart failure
Curr Cardiol Rep, 9 (3), 236-41
DOI 10.1007/BF02938356, PubMed 17470337
Potential mechanisms of benefit with thalidomide in chronic heart failure
Am J Cardiovasc Drugs, 7 (2), 127-34
DOI 10.2165/00129784-200707020-00004, PubMed 17503883
[Apoptosis and cardiovascular disease]
Tidsskr Nor Laegeforen, 123 (7), 930-2
PubMed 12737064
Other articles
Case report: First case of Borrelia miyamotoi meningitis in an immunocompromised patient in Norway
IDCases, 33, e01867
DOI 10.1016/j.idcr.2023.e01867, PubMed 37577049
[How often should blood tests be repeated?]
Tidsskr Nor Laegeforen, 143 (1)
DOI 10.4045/tidsskr.22.0658, PubMed 36655958
Correction: Impact of neighbourhood-level socioeconomic status, traditional coronary risk factors, and ancestry on age at myocardial infarction onset: A population-based register study
BMC Cardiovasc Disord, 22 (1), 499
DOI 10.1186/s12872-022-02938-6, PubMed 36418934
[Not Available]
Tidsskr Nor Laegeforen, 136 (16), 1325
DOI 10.4045/tidsskr.16.0688, PubMed 27637034
[Over 80 years and myocardial infarction]
Tidsskr Nor Laegeforen, 136 (12-13), 1058
DOI 10.4045/tidsskr.16.0458, PubMed 27381768
[First choice in empiric treatment of sepsis]
Tidsskr Nor Laegeforen, 124 (24), 3264
PubMed 15645537
[More about use of antibiotics in sepsis]
Tidsskr Nor Laegeforen, 124 (22), 2942; author reply 2942
PubMed 15550978
[Empiric sepsis treatment in Norway]
Tidsskr Nor Laegeforen, 124 (16), 2154; author reply 2154-5
PubMed 15334146
Theses
Autocrine/paracrine regulatory mechanisms and myocardial remodeling during ischemic heart failure: an experimental study in rats with special emphasis on the role of myocardial endothelin and adrenomedullin
In Hjerteforum, Supplement, Norsk cardiologisk selskap, Oslo, 3, 2000, 1 b. (flere pag.)
BIBSYS 000829781